市場調查報告書
商品編碼
1298809
2023-2028年按類型(複合藥片、黃體酮藥片和其他)、配銷通路(零售店、網店和其他)和地區分類的緊急避孕藥市場Emergency Contraceptive Pills Market by Type (Combination Pills, Progesterone Pills, and Others), Distribution Channel (Retail Stores, Online Stores, and Others), and Region 2023-2028 |
全球緊急避孕藥市場規模在2022年達到5.612億美元。展望未來,IMARC Group預計,到2028年,市場規模將達到7.367億美元,在2023-2028年期間呈現4.74%的成長率(CAGR)。大眾對避孕和計劃生育的認知不斷提高,政府和非政府組織(NGO)實施支持性政策,以及最近非荷爾蒙類緊急避孕藥的發展,是推動市場發展的一些關鍵因素。
緊急避孕藥(ECPs)是指用於防止意外懷孕的節育藥物。它們使用合成激素製造,如左炔諾孕酮,延遲排卵,改變子宮內膜,並防止卵子受精。 ECPs被廣泛用於傳統避孕方法失敗時、無保護的性交後、作為缺少常規避孕藥的備份,以及性侵犯犯罪的受害者。它們是安全的、具有成本效益的、可獲得的和高度便利的藥物,不會造成長期的生育問題,成功地防止意外懷孕,並消除了墮胎的需要。 ECPs還能更好地控制生殖健康,賦予婦女權力,減少焦慮和壓力,並將副作用降到最低。
群眾對避孕和計劃生育的認知不斷提高是推動市場成長的關鍵因素之一。緊急避孕藥作為一種安全、方便、高度舒適的緊急避孕方式被婦女廣泛使用,它可以防止意外懷孕,維護隱私,並將副作用和未來併發症的風險降到最低。此外,由於無保護的性交和性侵犯導致的意外懷孕的發生率上升,產品的廣泛使用也是另一個成長的誘導因素。此外,政府和非政府組織(NGO)實施支持性政策,傳播意識,教育群眾,並提供方便的緊急避孕措施,對市場成長產生了積極的影響。此外,最近開發的非激素類ECPs,含有醋酸烏利司他,與傳統的左炔諾孕酮藥丸相比,能阻斷體內的孕激素受體,產生的副作用更少,這也為市場成長提供了動力。除此之外,由於全球範圍內對女性健康和福祉的日益關注,產品的採用率不斷上升,有利於市場的成長。除此之外,對不需要處方的非處方藥(OTC)產品的需求成長,以及婦女在緊急情況下可以方便地獲得這些產品,也支持了市場的成長。此外,製造商通過社交媒體、影響者行銷、電視(TV)廣告和名人代言開展的積極宣傳和品牌推廣活動,也促進了市場成長。其他因素,包括消費者支出能力的提高,廣泛的研究和開發(R&D)活動,以及在電子商務平台上容易獲得產品,預計將推動市場成長。
請注意,這只代表部分公司的名單,完整的名單已在報告中提供。
The global emergency contraceptive pills market size reached US$ 561.2 Million in 2022. Looking forward, IMARC Group expects the market to reach US$ 736.7 Million by 2028, exhibiting a growth rate (CAGR) of 4.74% during 2023-2028. The increasing awareness among the masses regarding contraception and family planning, the implementation of supportive policies by governments and non-governmental organizations (NGOs), and the recent development of non-hormonal ECPs represent some of the key factors driving the market.
Emergency contraceptive pills (ECPs) refer to birth control medications used for preventing unwanted pregnancies. They are manufactured using synthetic hormones, such as levonorgestrel, which delays ovulation, changes the linings of the uterus, and prevents egg fertilization. ECPs are widely used during the failure of traditional methods of contraception, after unprotected sexual intercourse, as a backup for missing routine birth control pills, and by the victims of sexual assault crimes. They are safe, cost-effective, accessible, and highly convenient medications that do not cause long-term fertility issues, successfully prevent unintended pregnancies, and eliminate the need for abortions. ECPs also provide better control over reproductive health, empower women, reduce anxiety and stress, and minimize side effects.
The increasing awareness among the masses regarding contraception and family planning is one of the key factors propelling the market growth. ECPs are widely used by women as a safe, convenient, and highly comfortable form of emergency contraception, which prevents unwanted pregnancies, maintains privacy, and minimizes the risks of side effects and future complications. Along with this, the widespread product utilization due to rising incidences of unintended pregnancies owing to unprotected intercourse and sexual assault is acting as another growth-inducing factor. Furthermore, the implementation of supportive policies by governments and non-governmental organizations (NGOs) to spread awareness, educate the masses, and provide easy access to emergency contraception is positively influencing the market growth. Additionally, the recent development of non-hormonal ECPs, which contains ulipristal acetate that blocks progesterone receptors in the body and produces fewer side effects compared to traditional levonorgestrel-based pills, is providing an impetus to the market growth. Apart from this, the rising product adoption owing to the increasing focus on women's health and well-being across the globe is favoring the market growth. Besides this, the growing demand for over-the-counter (OTC) products that don't require prescriptions and can be easily accessed by women in case of emergency is supporting the market growth. Moreover, aggressive promotional and branding campaigns by manufacturers through social media, influencer marketing, television (TV) commercials, and celebrity endorsement are contributing to the market growth. Other factors, including rising expenditure capacities of consumers, extensive research and development (R&D) activities, and easy product availability across e-commerce platforms, are anticipated to drive the market growth.
IMARC Group provides an analysis of the key trends in each segment of the global emergency contraceptive pills market, along with forecasts at the global, regional, and country levels from 2023-2028. Our report has categorized the market based on type and distribution channel.
Combination Pills
Progesterone Pills
Others
The report has provided a detailed breakup and analysis of the emergency contraceptive pills market based on the type. This includes combination pills, progesterone pills, and others. According to the report, combination pills represented the largest segment.
Retail Stores
Online Stores
Others
A detailed breakup and analysis of the emergency contraceptive pills market based on the distribution channel has also been provided in the report. This includes retail stores, online stores, and others. According to the report, retail stores accounted for the largest market share.
North America
United States
Canada
Asia Pacific
China
Japan
India
South Korea
Australia
Indonesia
Others
Europe
Germany
France
United Kingdom
Italy
Spain
Russia
Others
Latin America
Brazil
Mexico
Others
Middle East and Africa
The report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa. According to the report, North America was the largest market for emergency contraceptive pills. Some of the factors driving the North America emergency contraceptive pills market included the increasing awareness regarding women's health, supportive government policies, and significant technological advancements.
The report has also provided a comprehensive analysis of the competitive landscape in the global emergency contraceptive pills market. Competitive analysis such as market structure, market share by key players, player positioning, top winning strategies, competitive dashboard, and company evaluation quadrant has been covered in the report. Also, detailed profiles of all major companies have been provided. Some of the companies covered include Afaxys Pharma LLC, Foundation Consumer Healthcare LLC, Gedeon Richter Plc, HLL Lifecare Limited, Perrigo Company plc, Piramal Enterprises Ltd., Syzygy Healthcare Solutions LLC, etc. Kindly note that this only represents a partial list of companies, and the complete list has been provided in the report.
Kindly note that this only represents a partial list of companies, and the complete list has been provided in the report.